Soleno Therapeutics, Inc. Series A Warrant
SLNOW
SLNOW was delisted on the 8th of November, 2019.
5 hedge funds and large institutions have $124K invested in Soleno Therapeutics, Inc. Series A Warrant in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
464% more capital invested
Capital invested by funds: $22K → $124K (+$102K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
+$110K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.99K |
| 3 |
VF
Virtu Financial
New York
|
+$1.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $112K | +$110K | +188,772 | New |
|
|
2
UBS Group
Zurich,
Switzerland
| $6K | +$4.99K | +8,559 | +460% |
|
3
Hudson Bay Capital Management
Stamford,
Connecticut
| $4K | – | – | – |
|
|
BG
4
Bollard Group
Boston,
Massachusetts
| $1K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| $1K | +$1.46K | +2,503 | New |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$2K | -2,706 | Closed |
|
SLNOW Hedge Fund Activity: Q3 2017 in Review
5 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Soleno Therapeutics, Inc. Series A Warrant (SLNOW) for Q3 2017, worth a combined $124K — up 464% from $22K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SLNOW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Vivo Capital, opening a new position worth an estimated $110K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $2K sold.
- 5 institutional investors held Soleno Therapeutics, Inc. Series A Warrant (SLNOW) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $124K of Soleno Therapeutics, Inc. Series A Warrant stock for Q3 2017, up 464% quarter-over-quarter.
- 2 funds opened new Soleno Therapeutics, Inc. Series A Warrant positions in Q3 2017 and 1 closed out, a net change of +1 holder.
- The largest Soleno Therapeutics, Inc. Series A Warrant buyer in Q3 2017 was Vivo Capital, an estimated $110K added.
- The largest Soleno Therapeutics, Inc. Series A Warrant seller in Q3 2017 was Two Sigma Securities, an estimated $2K sold.
Based on aggregated 13F filings for Q3 2017.